It is a chemicals private limited company based in Kukatpally, Hyderabad, Telangana, India, established in 2019.
2019 | Kukatpally, Hyderabad, Telangana, India | ActiveRx Drugs Novel Care Private Limited, a active private limited company, was established on 13 September 2019 in Kukatpally, Hyderabad, Telangana, India. Engaging in basic chemicals except fertilizers and nitrogen compounds within the chemicals sector, it holds CIN: U24110TG2019PTC135423. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Ramadevi Veeravalli (Director), Umamaheswara Rao Veravalli (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat No 403, Plot No 33 & 34 Sai Krishna Villa, A.S. Raju Ngr Colony, Kukatpally, Hyderabad, Telangana, 500072.
U24110TG2019PTC135423
135423
13 September 2019
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rx Drugs Novel Care Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramadevi Veeravalli | Director | 13 Sep 2019 | Current |
| Umamaheswara Rao Veravalli | Director | 13 Sep 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rx Drugs Novel Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.97% increase. The company also saw a substantial fall in profitability, with a 14.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rx Drugs Novel Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rx Drugs Novel Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rx Drugs Novel Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx Drugs Novel Care's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rx Drugs Novel Care Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Rx Drugs Novel Care Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
The activity Ramadevi Veeravalli was appointed as a Director was appointed as a Director on 13 Sep 2019 & has been associated with this company since 6 years 3 months . was completed.
Progress on Umamaheswara Rao Veravalli was appointed as a Director was appointed as a Director on 13 Sep 2019 & has been associated with this company since 6 years 3 months . was documented.
Progress on Rx Drugs Novel Care Private Limited was registered on 13 Sep 2019 with Roc Hyderabad & aged 6 years 3 months as per MCA records. was documented.
The CIN of Rx Drugs Novel Care Private Limited is U24110TG2019PTC135423.
Rx Drugs Novel Care Private Limited is headquartered at Flat No 403, Plot No 33 & 34 Sai Krishna Villa, A.S. Raju Ngr Colony, Kukatpally, Hyderabad, Telangana, 500072.
Rx Drugs Novel Care Private Limited was incorporated on 13 September 2019.
The current directors of Rx Drugs Novel Care Private Limited are
The primary industry of Rx Drugs Novel Care Private Limited is Chemicals.
Rx Drugs Novel Care Private Limited is unlisted.
The authorized capital of Rx Drugs Novel Care Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX